AGA presents a new season of Inside Scope based off the Perspectives column from our newspaper, GI & Hepatology News. In this series, we’ll feature guests debating or offering complementary opinions on current hot topics in GI. In this episode, filmed live at Digestive Disease Week® (DDW) 2025, GI & Hepatology News editor Gyanprakash A. Ketwaroo, MD, MSc, hosts a discussion with Moamen Gabr, MD, MSC and Jeffrey D. Mosko, MD, MSc on the best practices for removing large or complex colon polyps.
Author: Abhay Panchal
MedCore Partners and GI Alliance have opened a new Ambulatory Surgery Center and managed clinic in Kansas City, designed for high-quality, outpatient GI care. The facility features advanced surgical suites, integrated tech, and seamless care coordination. This marks another strategic move by GI Alliance—now over 1,000 gastroenterologists strong—as it scales its national footprint through physician-led, state-of-the-art GI facilities.
Doximity has launched a free, HIPAA-compliant AI medical scribe available to all verified U.S. clinicians, undercutting high-cost competitors. The tool integrates seamlessly with its Dialer platform and aims to reduce burnout, especially in underserved clinics. With 80% of U.S. physicians on its network, Doximity is poised to reshape the ambient documentation space.
2025 is bringing a wave of groundbreaking advancements in gastrointestinal care, with emerging technologies that aim to improve GI diagnoses, reduce recovery times and offer more effective treatments for patients. From AI integration to minimally invasive procedures, here are eight breakthroughs shaping the future of GI care.
🚻 Key Insights
While deal volume in gastroenterology has declined—down from 27 deals in 2022 to just 11 in 2024—the fundamentals for consolidation remain strong. KPMG’s Q1 2025 report makes one thing clear: GI remains a highly fragmented, growth-ready specialty that continues to attract private equity and strategic buyers. What’s driving this evolution? Why this matters:The drop in deal count doesn’t signal weakness—it reflects a maturing landscape where quality, not quantity, defines activity. Practices that modernize and offer scalable infrastructure are best positioned to capitalize on future waves of consolidation.
H. pylori infection affects nearly half the world’s population and is a leading, yet preventable, cause of stomach cancer. A new analysis published in Nature Medicine projects that 15.6 million people born between 2008–2017 could develop stomach cancer without intervention. Astonishingly, 76% of those cases are linked to H. pylori and could be avoided with early screen-and-treat strategies.The burden is highest in Asia and growing among people under 50, yet treatment remains accessible—antibiotic combinations with proton pump inhibitors are both effective and affordable. Experts call for national prevention programs to mitigate what could be a looming public health crisis
At the intersection of medicine and machine learning, Dr. Ali Soroush, Assistant Professor at the Icahn School of Medicine at Mount Sinai, is pioneering the responsible integration of generative AI into gastroenterology. From automating EHR data extraction to enhancing cancer screening workflows, his work is focused on solving real-world GI challenges through scalable AI tools. Dr. Soroush is not only transforming practice with innovations like a patented system for processing colonoscopy data, but also shaping the next generation of AI-literate GI physicians through the AI Scholars Program and core fellow training at Mount Sinai. His leadership helps gastroenterologists move beyond…
NYU Langone Hospital—Long Island has appointed Galen Leung, MD as Chief of Advanced Endoscopy. Dr. Leung is a nationally recognized expert in third space (intramural) endoscopy, specializing in pancreaticobiliary diseases and early-stage GI cancer treatment.
Viome Life Sciences and Scripps Research have partnered to develop the first RNA-based at-home test to detect precancerous colon polyps—aiming to shift CRC prevention from invasive colonoscopy to early molecular detection. Key details: If successful, this could mark a major advancement in noninvasive CRC prevention by targeting polyp-stage intervention.